Try GOLD - Free
Swiggy scales up Noice to expand private-label play
Mint Chennai
|January 12, 2026
Swiggy’s Noice expanded its supplier base from 40 to nearly 70 contract manufacturers
The brand has moved beyond premium snacks and sweets, adding dairy, eggs, fresh foods, beverages and ready-to-cook items.
(REUTERS)
Swiggy’s private-label brand, Noice, which debuted on its quick-commerce platform Instamart, has expanded rapidly by adding contract manufacturers across various categories, including bakery, snacks, confectionery, dairy, eggs and perishable foods.
The push expanded Noice’s range and supplier base since August 2025. Two people aware of the company’s operations said Noice has grown from about 200 stock-keeping units (SKUs) to about 350 now, and from about 40 contract manufacturers to close to 70 over the same period, as Swiggy adds products across new categories.
What began as a small-batch, premium range, centred on Indian sweets, snacks, cookies, baked items sourced from small kitchens and manufacturers—has widened sharply in recent months as Noice adds more categories and partners, said the second person aware of Instamart’s operations.
“Recent additions include beverages, ready-to-cook items, and dairy and fresh items like eggs, dosa batter and paneer,” the person added.
This story is from the January 12, 2026 edition of Mint Chennai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Chennai
Mint Chennai
Lenskart wants artificial intelligence to test your eyes
It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery
3 mins
January 13, 2026
Mint Chennai
More companies to take a hit as labour codes debut
Reworked gratuity and leave encashments spell additional expenses for India Inc
2 mins
January 13, 2026
Mint Chennai
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Chennai
Trump’s investigation of Powell is also a warning to the next Fed chair
The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.
3 mins
January 13, 2026
Mint Chennai
States flag Almont-Kid syrup as tests find contaminants
Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol
1 mins
January 13, 2026
Mint Chennai
India at 100: Our choices today will define the next two decades
India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path
4 mins
January 13, 2026
Mint Chennai
Now, inheritance works without probate—but why it still matters
Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases
6 mins
January 13, 2026
Mint Chennai
Why VCs have a new deep-tech playbook
where fundraising starts to drag,\" said Chand.
1 min
January 13, 2026
Mint Chennai
TCS, HCLTech deliver Q3 revenue surprise
clearer.
2 mins
January 13, 2026
Mint Chennai
US productivity is rising and it risks warping monetary policy
America's neutral rate ought to be going up but will the Fed listen?
3 mins
January 13, 2026
Listen
Translate
Change font size
